SEC Form 4 · accession 0001225208-17-012573

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Daniel J. Brennan

Officer — EVP and CFO

Period of report

Jul 11, 2017

Accepted (ET)

Jul 12, 2017 · 4:08 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000885725

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jul 11, 2017	M	20,461	$7.41	A	235,421	D
Common Stock	Jul 11, 2017	M	16,863	$17.26	A	252,284	D
Common Stock	Jul 11, 2017	M	15,086	$16.31	A	267,370	D
Common Stock	Jul 11, 2017	M	13,661	$13.08	A	281,031	D
Common Stock	Jul 11, 2017	M	12,422	$7.16	A	293,453	D
Common Stock	Jul 11, 2017	M	7,572	$7.39	A	301,025	D
Common Stock	Jul 11, 2017	M	6,093	$6.28	A	307,118	D
Common Stock^F2	Jul 11, 2017	S	92,158	$27.4753	D	214,960	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$7.41	Jul 11, 2017	M	20,461	D	—	Feb 16, 2020	Common Stock	20,461	61,386	D
Stock Option (Right to Buy)^F4	$17.26	Jul 11, 2017	M	16,863	D	—	Feb 22, 2026	Common Stock	16,863	67,454	D
Stock Option (Right to Buy)^F5	$16.31	Jul 11, 2017	M	15,086	D	—	Feb 23, 2025	Common Stock	15,086	60,345	D
Stock Option (Right to Buy)^F6	$13.08	Jul 11, 2017	M	13,661	D	—	Feb 24, 2024	Common Stock	13,661	54,645	D
Stock Option (Right to Buy)^F7	$6.28	Jul 11, 2017	M	6,093	D	—	Feb 27, 2022	Common Stock	6,093	18,280	D
Stock Option (Right to Buy)^F8	$7.16	Jul 11, 2017	M	12,422	D	—	Feb 28, 2021	Common Stock	12,422	37,268	D
Stock Option (Right to Buy)^F9	$7.39	Jul 11, 2017	M	7,572	D	—	Feb 28, 2023	Common Stock	7,572	22,716	D

Explanation of responses

F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.29 to $27.58, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3Grant to the reporting person of an option to purchase 102,308 shares of common stock vesting in four equal annual installments beginning on February 16, 2011, the first anniversary of the grant.
F4Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the grant.
F5Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the grant.
F6Grant to the reporting person of an option to purchase a specified number of shares of common stock in four equal annual installments beginning on February 24, 2015, the first anniversary of the grant.
F7Grant to the reporting person of an option to purchase 30,466 shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the grant.
F8Grant to the reporting person of an option to purchase 62,112 shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant.
F9Grant to the reporting person of an option to purchase 37,860 shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the grant.